Resources Contact Us Home
Recombinant vaccine for diseases caused by encapsulated organisms

Image Number 5 for United States Patent #6326001.

Vaccines for diseases caused by normally encapsulated organisms are produced by genetically modifying those organisms by deleting the genes encoding for capsule synthesis or a portion thereof sufficient to produce non-capsulated mutants of the organisms. As an example, a live, attenuated strain of Actinobacillus pleuropneumoniae genetically modified with a large deletion in a chromosomal regions of the DNA which encodes for capsule synthesis is a safe and effective vaccine against swine pleuropneumonia.

  Recently Added Patents
Automated hotfix handling model
Communication apparatus, power supply control method, display apparatus, communication method, and computer program product
Selecting from a plural of energy saving modes
Error detection and recovery tool for logical volume management in a data storage system
Treatment of cancer using the sodium salt of a benzoic acid derivative
Phenethanolamine derivatives for treatment of respiratory diseases
Image display device and capsule endoscope system
  Randomly Featured Patents
Interference management with MIMO in a peer-to-peer network
On-line self-calibration of mass airflow sensors in reciprocating engines
Seat adjusting apparatus
3GT/4GT biocomponent fiber and preparation thereof
Voice recognition status display
Method of externally covering metal objects
Architecture for a hybrid STM/ATM add-drop multiplexer
Precision resistor fabrication employing tapped resistive elements
Semiconductor device and method and apparatus for manufacturing semiconductor device
Electronically controllable brake operating system for motor vehicles